PHH2 Stock Overview
Paul Hartmann AG manufactures and sells medical and care products in Germany, rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Paul Hartmann AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €207.00 |
| 52 Week High | €244.00 |
| 52 Week Low | €178.50 |
| Beta | 0.48 |
| 1 Month Change | -3.72% |
| 3 Month Change | 4.55% |
| 1 Year Change | -10.78% |
| 3 Year Change | -45.67% |
| 5 Year Change | -34.08% |
| Change since IPO | 73.62% |
Recent News & Updates
Paul Hartmann's (FRA:PHH2) Problems Go Beyond Weak Profit
Mar 25
Calculating The Fair Value Of Paul Hartmann AG (FRA:PHH2)
Mar 08Getting In Cheap On Paul Hartmann AG (FRA:PHH2) Is Unlikely
Jan 31Recent updates
Paul Hartmann's (FRA:PHH2) Problems Go Beyond Weak Profit
Mar 25Calculating The Fair Value Of Paul Hartmann AG (FRA:PHH2)
Mar 08Getting In Cheap On Paul Hartmann AG (FRA:PHH2) Is Unlikely
Jan 31Paul Hartmann (FRA:PHH2) Has A Somewhat Strained Balance Sheet
Nov 16The Returns On Capital At Paul Hartmann (FRA:PHH2) Don't Inspire Confidence
Jul 05Is Paul Hartmann (FRA:PHH2) A Risky Investment?
May 06Paul Hartmann's (FRA:PHH2) Returns On Capital Not Reflecting Well On The Business
Jan 07Here's What's Concerning About Paul Hartmann's (FRA:PHH2) Returns On Capital
Sep 03Here's Why Paul Hartmann (FRA:PHH2) Can Manage Its Debt Responsibly
Apr 02Paul Hartmann (FRA:PHH2) Shareholders Will Want The ROCE Trajectory To Continue
Mar 09Is Paul Hartmann (FRA:PHH2) Using Too Much Debt?
Nov 24There's Been No Shortage Of Growth Recently For Paul Hartmann's (FRA:PHH2) Returns On Capital
May 19We Think Paul Hartmann (FRA:PHH2) Can Manage Its Debt With Ease
Apr 12Should You Buy Paul Hartmann AG (FRA:PHH2) For Its Dividend?
Mar 25Does Paul Hartmann's (FRA:PHH2) Share Price Gain of 29% Match Its Business Performance?
Feb 24Paul Hartmann AG's (FRA:PHH2) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Feb 03We're Watching These Trends At Paul Hartmann (FRA:PHH2)
Dec 29
How Does Paul Hartmann AG (FRA:PHH2) Fare As A Dividend Stock?
Dec 11If You Had Bought Paul Hartmann's (FRA:PHH2) Shares Three Years Ago You Would Be Down 16%
Nov 23Shareholder Returns
| PHH2 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.0% | -5.1% | -1.5% |
| 1Y | -10.8% | -9.0% | 0.9% |
Return vs Industry: PHH2 underperformed the German Medical Equipment industry which returned -6.2% over the past year.
Return vs Market: PHH2 underperformed the German Market which returned -0.4% over the past year.
Price Volatility
| PHH2 volatility | |
|---|---|
| PHH2 Average Weekly Movement | 5.5% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PHH2 has not had significant price volatility in the past 3 months.
Volatility Over Time: PHH2's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1818 | 10,168 | Britta Fuenfstueck | hartmann.info |
Paul Hartmann AG manufactures and sells medical and care products in Germany, rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers disinfectant products for hands, surface, and instruments; cleaning, skin care, and skin antisepsis products, as well as Sterillium, a hand disinfectant; incontinence management products; and personal healthcare products, such as diagnostic devices and first aid products.
Paul Hartmann AG Fundamentals Summary
| PHH2 fundamental statistics | |
|---|---|
| Market cap | €745.87m |
| Earnings (TTM) | €28.42m |
| Revenue (TTM) | €2.37b |
25.9x
P/E Ratio0.3x
P/S RatioIs PHH2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHH2 income statement (TTM) | |
|---|---|
| Revenue | €2.37b |
| Cost of Revenue | €1.09b |
| Gross Profit | €1.28b |
| Other Expenses | €1.25b |
| Earnings | €28.42m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.00 |
| Gross Margin | 54.03% |
| Net Profit Margin | 1.20% |
| Debt/Equity Ratio | 14.9% |
How did PHH2 perform over the long term?
See historical performance and comparisonDividends
3.9%
Current Dividend Yield100%
Payout RatioDoes PHH2 pay a reliable dividends?
See PHH2 dividend history and benchmarks| Paul Hartmann dividend dates | |
|---|---|
| Ex Dividend Date | Apr 29 2024 |
| Dividend Pay Date | May 02 2024 |
| Days until Ex dividend | 9 days |
| Days until Dividend pay date | 12 days |
Does PHH2 pay a reliable dividends?
See PHH2 dividend history and benchmarks